Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Pediatric Rheumatology
Do you routinely pursue cardiac evaluation in children presenting with post-streptococcal reactive arthritis given the diagnostic overlap with acute rheumatic fever?
Related Questions
Do you always pursue testing for NOD2 mutations when you are suspecting a diagnosis of Blau syndrome?
In patients with possible early SLE or undifferentiated disease can multiomics be used to help predict what disease phenotype they will develop?
Do you recommend genetic screening for FMF in asymptomatic first-degree relatives with a strong family history (multiple family members, severe/refractory disease)?
Would you consider combination belimumab and anakinra for a patient who has SLE and MAS?
When would you consider use of emapalumab for HLH/MAS ?
What is your approach to screening patients with sJIA for associated lung disease?
Do you continue biologics in sJIA patients who develop lung disease on anti IL-1 or anti IL-6 therapies?
How would you approach management of a patient with sJIA that was previously well controlled on tocilizumab but is now having ongoing joint disease activity?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
In a young patient who was vaccinated to chickenpox as a child (no previous varicella infection) should the patient receive a shingles vaccine prior to starting Rinvoq?
